Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A truncated HIV Tat demonstrates potent and specific latency reversal activity

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00417-23Source: DataRank Database

A truncated HIV Tat demonstrates potent and specific latency reversal activity is a research paper published in Antimicrobial Agents and Chemotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.85)OA: hybridTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Marion Pardons ORCID,Erik Nijs,Nick Verheyen ORCID,Koen Dockx,Christel Van den Eynde

Live enrichment

PubMed:37874295 PMC:PMC10649039 OpenAlex:https://openalex.org/W4387893729

Agentschap Innoveren en Ondernemen

Grant: HBC.2018.2278

HHS | National Institutes of Health

Grant: UM1AI126619

NIAID NIH HHS

Grant: UM1 AI164567

National Institutes of Health

Grant: 5UM1AI126619-02

Collaboratory of AIDS Researchers for Eradication (CARE)

FWCI

1.85

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.00417-23

publisherhttps://doi.org/10.1128/aac.00417-23

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00417-23

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37874295

repositoryhttp://hdl.handle.net/1854/LU-01JMFB5ZBRNZQZM1R7ZVFV3GD4

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionHIV/AIDS drug development and treatment0301 basic medicine03 medical and health sciencesHumansCD4-Positive T-LymphocytesHIV InfectionsProvirusesVirus ActivationVirus LatencyVirus Replicationtat Gene Products, Human Immunodeficiency VirusHIV-1

MeSH Terms

HumansProvirusesVirus ActivationVirus ReplicationCD4-Positive T-LymphocytesHIV-1HIV InfectionsVirus Latencytat Gene Products, Human Immunodeficiency Virus

Keywords

ProvirusCartVirus latencyBiologyVirologyLatency (audio)Ex vivoCD8Viral replicationImmune systemVirusGeneImmunologyIn vivoGeneticsHIVTatLatencyCD4(+) T-CELLSCD4-Positive T-LymphocytesHIV InfectionsVirus ReplicationAntiviral AgentsANTIRETROVIRAL THERAPYProvirusesINFECTIONMedicine and Health SciencesHumansTRANSCRIPTIONELONGATION-FACTORSBiology and Life SciencesINHIBITORIN-VITROEX-VIVOHUMAN-IMMUNODEFICIENCY-VIRUSHIV-1RESERVOIRVirus Activationtat Gene Products, Human Immunodeficiency Virus

Sustainable Development Goals

SDG 0: Good health and well-being

A truncated HIV Tat demonstrates potent and specific latency reversal activity

FAIR Checklist

Authors (18)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)